Literature DB >> 29575754

Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.

Vinay Trivedi-Parmar1, Michael J Robertson1, José A Cisneros1, Stefan G Krimmer1, William L Jorgensen1.   

Abstract

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that is implicated in the regulation of inflammation, cell proliferation, and neurological disorders. MIF is also an enzyme that functions as a keto-enol tautomerase. Most potent MIF tautomerase inhibitors incorporate a phenol, which hydrogen bonds to Asn97 in the active site. Starting from a 113-μm docking hit, we report results of structure-based and computer-aided design that have provided substituted pyrazoles as phenol alternatives with potencies of 60-70 nm. Crystal structures of complexes of MIF with the pyrazoles highlight the contributions of hydrogen bonding with Lys32 and Asn97, and aryl-aryl interactions with Tyr36, Tyr95, and Phe113 to the binding.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  MIF inhibitors; phenol bioisosteres; protein crystallography; pyrazoles; tautomerase

Mesh:

Substances:

Year:  2018        PMID: 29575754      PMCID: PMC5990473          DOI: 10.1002/cmdc.201800158

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  40 in total

1.  ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.

Authors:  Yousef Al-Abed; Darrin Dabideen; Bayan Aljabari; Aline Valster; Davorka Messmer; Mahendar Ochani; Mahira Tanovic; Kanta Ochani; Michael Bacher; Ferdinando Nicoletti; Christine Metz; Valentin A Pavlov; Edmund J Miller; Kevin J Tracey
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

Review 2.  Structure-brain exposure relationships.

Authors:  Stephen A Hitchcock; Lewis D Pennington
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

Review 3.  MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.

Authors:  Joshua Bloom; Shan Sun; Yousef Al-Abed
Journal:  Expert Opin Ther Targets       Date:  2016-11-01       Impact factor: 6.902

Review 4.  Macrophage migration inhibitory factor.

Authors:  Elias Lolis; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2003-04       Impact factor: 6.902

5.  Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

Authors:  Zoe Cournia; Lin Leng; Sunilkumar Gandavadi; Xin Du; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

Review 6.  Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.

Authors:  Ciaran O'Reilly; Mohammad Doroudian; Leona Mawhinney; Seamas C Donnelly
Journal:  Med Res Rev       Date:  2016-01-18       Impact factor: 12.944

Review 7.  Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.

Authors:  Masaya Orita; Satoshi Yamamoto; Naoko Katayama; Shigeo Fujita
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 8.  Efficient drug lead discovery and optimization.

Authors:  William L Jorgensen
Journal:  Acc Chem Res       Date:  2009-06-16       Impact factor: 22.384

Review 9.  Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives.

Authors:  Lukas Pawig; Christina Klasen; Christian Weber; Jürgen Bernhagen; Heidi Noels
Journal:  Front Immunol       Date:  2015-08-21       Impact factor: 7.561

10.  A Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent Inhibitors.

Authors:  José A Cisneros; Michael J Robertson; Margarita Valhondo; William L Jorgensen
Journal:  J Am Chem Soc       Date:  2016-06-28       Impact factor: 15.419

View more
  4 in total

1.  Absolute Free Energy of Binding Calculations for Macrophage Migration Inhibitory Factor in Complex with a Druglike Inhibitor.

Authors:  Yue Qian; Israel Cabeza de Vaca; Jonah Z Vilseck; Daniel J Cole; Julian Tirado-Rives; William L Jorgensen
Journal:  J Phys Chem B       Date:  2019-10-07       Impact factor: 2.991

2.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

3.  Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel.

Authors:  Georgios Pantouris; Leepakshi Khurana; Anthony Ma; Erin Skeens; Krystle Reiss; Victor S Batista; George P Lisi; Elias J Lolis
Journal:  Cell Chem Biol       Date:  2020-05-19       Impact factor: 8.116

4.  Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative Inhibits d-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells.

Authors:  Zhangping Xiao; Angelina Osipyan; Shanshan Song; Deng Chen; Reinder A Schut; Ronald van Merkerk; Petra E van der Wouden; Robbert H Cool; Wim J Quax; Barbro N Melgert; Gerrit J Poelarends; Frank J Dekker
Journal:  J Med Chem       Date:  2022-01-18       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.